To the best of our knowledge, the present study is the first case report of a possible abscopal effect observed in a PD-L1-negative advanced esophageal cancer patient treated with an anti-PD-1 monoclonal antibody plus SBRT. This evidence concerns the gene CD274 and esophageal cancer.